• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Long-Read RNA Sequencing Improves Diagnostic Resolution for Rare Mendelian Disorders

by
November 16, 2026
in Health
Reading Time: 3 mins read
0
Long-Read RNA Sequencing Improves Diagnostic Resolution for Rare Mendelian Disorders

Long-Read RNA Sequencing Improves Diagnostic Resolution for Rare Mendelian Disorders

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Long-read RNA sequencing delivers enhanced resolution and mechanistic insights compared with standard short-read RNA sequencing in more than half of investigated cases displaying positive transcriptional findings. In an evaluation focusing on rare Mendelian disorder diagnosis, the approach yielded a streamlined analysis output while clarifying disease-associated alterations in 57 percent of positive cases within a control cohort and 80 percent of positive cases within an undiagnosed discovery cohort.

Transcriptome sequencing serves as a valuable tool for genetic variant interpretation and the identification of rare Mendelian conditions. Even so, standard short-read sequencing methodologies face substantial hurdles because of their inability to fully resolve complex transcriptional changes, which ultimately restricts their diagnostic potential. Long-read sequencing platforms overcome these constraints by sequencing full-length complementary DNA transcripts directly, addressing gaps where short reads struggle, although the overall diagnostic efficiency of this technology has required formal evaluation.

To evaluate clinical performance, investigators implemented long-read RNA sequencing using the PacBio Kinnex method across 50 individuals who also underwent paired short-read RNA sequencing. The assessments were conducted in clinically accessible human sample types, specifically whole blood, fibroblasts, and lymphoblastoid cell lines. The study population was divided into two distinct groups: a control cohort of 24 previously diagnosed individuals with known pathogenic messenger RNA aberrations, and an undiagnosed discovery cohort of 26 individuals presenting candidate DNA variants suitable for RNA sequencing analysis.

To support this comparative assessment, the research team generated comprehensive reference data sets and performed key benchmarking analyses across the sequencing platforms. Furthermore, the researchers developed a novel bioinformatics and analytical pipeline tailored to detect and capture pathogenic transcriptional alterations. This computational framework was designed to interrogate a broad spectrum of molecular anomalies, including aberrant splicing changes, quantitative gene expression changes, differential isoform usage, allelic biases, gene fusions, and the transcriptional consequences of structural variants.

The study demonstrated that the isoform-level resolution provided by long-read RNA sequencing offers several key technical advantages over standard short-read methods. These documented benefits include the direct phasing of variant consequences, the precise clarification of splice junction boundaries, accurate differential isoform usage analysis, and the identification of previously unrecognized transcriptional events. Additionally, the approach enabled detailed characterization of the consequences arising from structural variants and gene fusions, directly facilitating the first reported case of autosomal recessive Cleidocranial Dysplasia.

Alongside its diagnostic advantages, the investigators identified and highlighted critical technical limitations associated with long-read RNA sequencing technology. Specifically, the method exhibited poor capture of short isoforms and demonstrated uneven sequencing coverage across particular long transcripts. Nevertheless, the study concludes that long-read RNA sequencing streamlines transcriptome analysis in complex clinical scenarios, providing essential benchmarking data, analytical workflows, and foundational insights regarding the clinical application of full-length sequencing in rare disease diagnostics.

Subject of Research: Diagnostic evaluation of long-read RNA sequencing for rare Mendelian disorders

Article Title: Evaluating long-read RNA sequencing for Mendelian disorder diagnosis

Article References: Hou, H., Liang, Y., Pipko, N., Tsoi, C. T., Khan, M., Vessio, I. E., Stark, J. C., Gershon, A., Stanley, K. J., Couse, M., Salpeter, N., Simonian, R., Pulsifer, K., Acker, M., Pan, A. Y., Sidhu, J., Elango, S., Tavares, E., Dupuis, L., … Deshwar, A. R. (2026). Evaluating long-read RNA sequencing for Mendelian disorder diagnosis. Genome Medicine. https://doi.org/10.1186/s13073-026-01830-8

Image Credits: AI Generated

DOI: 10.1186/s13073-026-01830-8

Keywords: Long-read RNA sequencing, Short-read RNA sequencing, Mendelian disorders, PacBio Kinnex, Transcriptome analysis, Isoform-level resolution, Variant interpretation, Differential isoform usage, Splicing aberrations, Gene fusions, Structural variants, Allelic biases, Cleidocranial Dysplasia, Whole blood, Fibroblasts, Lymphoblastoid cell lines, Variant phasing, Bioinformatics pipeline

News Source: Juliet Wilcox. (November 16, 2026). Long-Read RNA Sequencing Improves Diagnostic Resolution for Rare Mendelian Disorders. Scienmag.

Tags: Allelic biasesbioinformatics pipelinecleidocranial dysplasiaDifferential isoform usagefibroblastsgene fusionsIsoform-level resolutionlong-read RNA sequencinglymphoblastoid cell linesMendelian disordersPacBio KinnexShort-read RNA sequencingSplicing aberrationsstructural variantsTranscriptome analysisvariant interpretationVariant phasingwhole blood
Share12Tweet7Share2ShareShareShare1

Related Posts

FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

November 19, 2026
Low-Virulence Bacteria Fail to Prove Causation in Spinal Disc Degeneration

Low-Virulence Bacteria Fail to Prove Causation in Spinal Disc Degeneration

November 19, 2026

Brain Potentials Fail to Reliably Track Opioid Analgesia During Anesthesia

November 19, 2026

Researchers Identify First Autoantibody-Mediated Phenocopy of C8 Deficiency in Lupus

November 19, 2026

POPULAR NEWS

  • Tryptophan Can Contribute to Seawater Iron Reduction at Lower pH

    Tryptophan Can Contribute to Seawater Iron Reduction at Lower pH

    29 shares
    Share 12 Tweet 7
  • Preserving Cervical Carotid Segments During Autopsy May Facilitate Subsequent Facial Embalming

    29 shares
    Share 12 Tweet 7
  • Adaptive Adversarial Network Boosts Seismic Fault Identification Accuracy Across Surveys

    29 shares
    Share 12 Tweet 7
  • Prenatal Testing Identifies Rare Mosaic Trisomy 14 in Early Severe Fetal Malformations

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

Low-Virulence Bacteria Fail to Prove Causation in Spinal Disc Degeneration

Brain Potentials Fail to Reliably Track Opioid Analgesia During Anesthesia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.